Co-Authors
This is a "connection" page, showing publications co-authored by Nicolas Hoertel and Frédéric Limosin.
Connection Strength
2.814
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms. Mol Psychiatry. 2021 Dec; 26(12):7098-7099.
Score: 0.961
-
Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study. Clin Pharmacol Ther. 2021 12; 110(6):1498-1511.
Score: 0.239
-
Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study. Br J Clin Pharmacol. 2021 10; 87(10):3766-3775.
Score: 0.233
-
Impact of the timing and adherence to face mask use on the course of the COVID-19 epidemic in France. J Travel Med. 2021 02 23; 28(2).
Score: 0.233
-
Observational study of haloperidol in hospitalized patients with COVID-19. PLoS One. 2021; 16(2):e0247122.
Score: 0.233
-
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19. Clin Drug Investig. 2021 Mar; 41(3):221-233.
Score: 0.232
-
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021 09; 26(9):5199-5212.
Score: 0.232
-
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France. Nat Med. 2020 Nov; 26(11):1801.
Score: 0.228
-
A stochastic agent-based model of the SARS-CoV-2 epidemic in France. Nat Med. 2020 09; 26(9):1417-1421.
Score: 0.223